All In Biotech

Drug Trial Radar · NCT07430085

Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKA

Postoperative Pain Outcomes After Use of Bupivacaine-Meloxicam Extended-Release Solution in Robot Assisted Total Knee Arthroplasty: A Prospective Study

Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Sep 3, 2026

Primary completion

Jan 31, 2028

Study completion Feb 28, 2028

Sponsor

Sponsor type
Academic, hospital or other
First posted
Feb 24, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 89 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective Cohort of patients who are scheduled for a Robot Assisted Total Knee Arthroplasty (RATKA). A prospective survey of patient reported outcome measures (Numeric Rating Scale) will be obtained postoperatively of 72 hours, as well as at the postoperative opioid consumption after 72 hours.

Conditions

  • Periarticular Block
  • Osteoarthritis (OA)
  • Osteoarthritis (OA) of the Knee
  • Pain After Surgery
  • Knee Arthroplasty, Total

Interventions

  • bupivacaine-meloxicam (extended release)Combination product

    These surgeons will be using Zynrelef (bupivacaine-meloxicam extended release) as a form of periarticular analgesia.

  • BupivacaineDrug

    These surgeons will be using the control injection (bupivacaine + ketorolac + lidocaine) as a form of periarticular analgesia.

  • KetorolacDrug

    These surgeons will be using the control injection (bupivacaine + ketorolac + lidocaine) as a form of periarticular analgesia.

  • Lidocaine (drug)Drug

    These surgeons will be using the control injection (bupivacaine + ketorolac + lidocaine) as a form of periarticular analgesia.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Amount of opioid medications used (measured in morphine milligrams equivalents)Time frame: From completion of surgery to 3 days post-op
  2. Patient reported outcome measure (Numeric Rating Scale)Time frame: From completion of surgery to 3 days post-op

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • AHN Orthopedic Surgery Cranberry Township

    Cranberry Township, Pennsylvania · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.